The first effective coronavirus vaccine can prevent 90% of people from getting COVID-19, a preliminary analysis shows.
Developers Pfizer and BioNTech have reported the first effective COVID-19 vaccine. The vaccine has been tested on 43,500 people across six countries, and no safety concerns have been flagged.
Pfizer and BioNTech also plan to apply for approval to use the vaccine by the end of the month.
Scientists have suggested that life could ‘be back to normal’ by early 2021. “I am probably the first guy to say that, but I will say that with some confidence,” said Sir John Bell, regius professor of medicine at Oxford University.
There are other vaccines that are in the phase 3 trial, otherwise known as the final stages of testing, but this is the first vaccine to show significant results.
To read the original story, click here.